Moreover, the induction of adiponectin by means of the PPARγ agonism suppresses the elevation in CCL2 levels by blocking TNF- α signaling, thereby attenuating obesity-associated PPAT inflammation [103]. Here, CCL2 is linked to obesity disorder.